Ausio header

 

Publications

photo

Schwen RJ, Jackson RL, Proudlock R.
Genotoxicity assessment of S-equol in bacterial mutation, chromosome aberration, and rodent micronucleus tests.
Food Chem Tox. 2010; 48: 3481-3485.

Jackson RL, Greiwe JS, Desai PB, Schwen RJ.
Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor β-agonist being developed for the treatment of menopausal symptoms.
Menopause. 2011; 18: 185-193.

Plomley JB, Jackson RL, Schwen RJ, Greiwe JS.
Development of liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for determination of free and total S-equol in human plasma and urine.
J Pharmaceut Biomed Anal. 2011; 55: 125-134.

Jackson RL, Greiwe JS, Schwen RJ.
Emerging evidence on the health benefits of S-equol, an estrogen receptor β agonist.
Nutr Rev. 2011; 69: 432-448.

Jackson RL, Greiwe JS, Schwen RJ.
Aging skin: estrogen receptor β agonists offer an approach to change the outcome.
Exp Dermatol. 2011; 20: 879-882.

Schwen RJ, Plomley JB, Jackson RL.
Toxicokinetics and lack of uterotropic effect of orally administered S-equol.
Food Chem Toxicol. 2012; 50: 1741-1748.

Schwen RJ, Henry K, Nguyen L, Jackson RL.
Elucidation of the metabolic pathway of AUS-131 (S-equol) in rat, cynomolgus monkey and man.
Food Chem Toxicol. 2012; 50: 2074-2083.

Schwen RJ, Henry KT, Jackson RL.
Absorption, distribution and excretion of (14C]-S-equol in the rat and cynomolgus monkey.
International Journal of Pharmacognosy and Phytochemical Research. 2013; 5: 155-163.

Jackson RL, Greiwe JS, Schwen RJ. (2013).
S-equol, a Natural Metabolite of Soy Daidzein, for the Treatment of Menopausal Symptoms and Osteoporosis in Postmenopausal Women.
In: Nutrition and Diet in Menopause. Valley Stream, NY: Humana Press. 131-140.

Jackson RL, Greiwe JS, Schwen RJ. (2014).
S-equol, an Antioxidant Metabolite of Soy Daidzein, and Oxidative Stress in Aging: A focus on Skin and on the Cardiovascular System.
In: Aging: Oxidative Stress and Dietary Antioxidants. London, UK: Elsevier Inc. 145-155.

 


 

 
   

Home Contact UsDirections